Evidence map›Paper›PMID 38087768›Full record

GuidelineEuropean journal of ophthalmology2024

Myopia management algorithm. Annexe to the article titled Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute.

Beáta Tapasztó, Daniel Ian Flitcroft, Wagih A Aclimandos, Jost B Jonas, Jan-Tjeerd H N De Faber, Zoltán Zsolt Nagy, Philippe G Kestelyn, Ingrida Januleviciene, Andrzej Grzybowski, Christina Nicolaeva Vidinova and 16 more

Open access · hybridAbstract readPractice GuidelineReview
In one paragraph

Guideline in European journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Italian consensus on pediatric myopia: findings from a three-round modified delphi study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Management of myopia: a mini-review.Medical hypothesis, discovery & innovation ophthalmology journal · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 11 countries.

Beáta TapasztóDepartment of Ophthalmology, Semmelweis University, Budapest, Hungary.
Daniel Ian FlitcroftTemple Street Children's Hospital, Dublin, Ireland.
Wagih A AclimandosKing's College Hospital, London, UK.
Jost B JonasDepartment of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Jan-Tjeerd H N De FaberRotterdam Eye Hospital, Rotterdam, The Netherlands.
Zoltán Zsolt NagyDepartment of Ophthalmology, Semmelweis University, Budapest, Hungary.
Philippe G KestelynDepartment of Ophthalmology, Ghent University, Ghent, Belgium.
Ingrida JanulevicieneLithuanian University of Health Sciences, Kaunas, Lithuania.ORCID 0000-0002-2660-7922
Andrzej GrzybowskiInstitute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland.
Christina Nicolaeva VidinovaDepartment of Ophthalmology, Military Medical Academy, Sofia, Bulgaria.
Jeremy A GuggenheimSchool of Optometry & Vision Sciences, Cardiff University, Cardiff, UK.
Jan Roelof PollingDepartment of Ophthalmology and Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
James S WolffsohnOptometry and Vision Science Research Group, College of Health and Life Sciences, Aston University, Birmingham, UK.
J Willem L TidemanDepartment of Ophthalmology and Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Peter M AllenVision and Hearing Sciences Research Centre, Anglia Ruskin University, Cambridge, UK.
Rigmor C BaraasNational Centre for Optics, Vision and Eye Care, University of South-Eastern Norway, Kongsberg, Norway.
Kathryn J SaundersCentre for Optometry and Vision Science, Ulster University, Coleraine, UK.ORCID 0000-0002-9289-5731
Sara J McCulloughCentre for Optometry and Vision Science, Ulster University, Coleraine, UK.
Lyle S GrayGlasgow Caledonian University, Glasgow, UK.
Siegfried WahlInstitute for Ophthalmic Research, University Tübingen, Tübingen, Germany.ORCID 0000-0003-3437-6711
Irina Yurievna SmirnovaSiberian Center for the Prevention and Treatment of Myopia "Glazka", Novosibirsk, Russia.
Marino FormentiDepartment of Physics, School of Science, University of Padova, Padova, Italy.
Hema RadhakrishnanDivision of Pharmacy and Optometry, University of Manchester, Manchester, UK.
Serge ResnikoffSchool of Optometry and Vision Science, University of New South Wales, Sydney, Australia.ORCID 0000-0002-5866-4446
János NémethDepartment of Ophthalmology, Semmelweis University, Budapest, Hungary.ORCID 0000-0001-8575-4888
SOE Myopia Consensus GroupEuropean Society of Ophthalmology, Rotterdam, The Netherlands.
Semmelweis University · HUUniversity of Ulster · GBAnglia Ruskin University · GBAston University · GBBrien Holden Vision Institute · AUCardiff University · GBCarl Zeiss (Germany) · DEErasmus MC · NLGhent University Hospital · BEGlasgow Caledonian University · GBHeidelberg University · DEKing's College Hospital · GBLithuanian University of Health Sciences · LTMilitary Medical Academy · BGRotterdam Eye Hospital · NLTemple Street Children's University Hospital · IEUniversity of Applied Sciences Utrecht · NLUniversity of Manchester · GBUniversity of Padua · ITUniversity of South-Eastern Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myopia is becoming increasingly common in young generations all over the world, and it is predicted to become the most common cause of blindness and visual impairment in later life in the near future. Because myopia can cause serious complications and vision loss, it is critical to create and prescribe effective myopia treatment solutions that can help prevent or delay the onset and progression of myopia. The scientific understanding of myopia's causes, genetic background, environmental conditions, and various management techniques, including therapies to prevent or postpone its development and slow its progression, is rapidly expanding. However, some significant information gaps exist on this subject, making it difficult to develop an effective intervention plan. As with the creation of this present algorithm, a compromise is to work on best practices and reach consensus among a wide number of specialists. The quick rise in information regarding myopia management may be difficult for the busy eye care provider, but it necessitates a continuing need to evaluate new research and implement it into daily practice. To assist eye care providers in developing these strategies, an algorithm has been proposed that covers all aspects of myopia mitigation and management. The algorithm aims to provide practical assistance in choosing and developing an effective myopia management strategy tailored to the individual child. It incorporates the latest research findings and covers a wide range of modalities, from primary, secondary, and tertiary myopia prevention to interventions that reduce the progression of myopia.

Indexed as

AlgorithmsMyopiaOphthalmologyDisease ManagementDisease ProgressionEuropeEyeglassesHumansSocieties, Medicalatropinemanagement algorithmMyopiamyopia control interventionsorthokeratologypre-myopiapreventive medicinescreeningtime spent outdoors

Identifiers

PMID38087768
PMCPMC11295429
OpenAlexW4389683113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.